BMJ 2008;336:1208 (31 May), doi:10.1136/bmj.39591.643681.DB
News
In brief
| The first 150 words of the full text of this article appear below. |
FDA asks Congress for more funds: Andrew von Eschenbach, commissioner of the US Food and Drug Administration, has said that the agency needs $275m (£140m; 
175m) more each year to ensure that imported drugs, medical devices, and foods are safe. The US has had problems recently with heparin for human use imported from China. President Bush asked for a $51m increase, but the FDA said this was not enough to cover higher costs.
Polypill will cost less than $10 a month: Initial clinical tests are about to start on a polypill, a combination of aspirin, a statin, and an angiotensin converting enzyme inhibitor, for patients who have had a myocardial infarction, says the World Heart Federation. The pill is being developed in a collaboration between the Spanish National Centre for Cardiovascular Research and the Ferrer laboratory in Spain and is predicted to cost less than $10 (£5; 6) a month.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article
- Full text
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Related content
Bookmark with
Tools
Services
Rapid responses for this article
There are no rapid responses for this article.Most read last week
Student BMJ
Risk of surgery for inflammatory bowel disease: record linkage studies
What can you learn from this BMJ paper? Read Leanne Tite's Paper+
